Thalomid?? (Thalidomide) Capsules
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 24 (2) , 87-117
- https://doi.org/10.2165/00002018-200124020-00002
Abstract
The sedative/hypnotic thalidomide was withdrawn from the worldwide market nearly 40 years ago, because of its teratogenic and neurotoxic effects. Thalidomide was later found to very effectively...Keywords
This publication has 118 references indexed in Scilit:
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- Recognition and Evaluation of Oncology-Related Symptoms in the Emergency DepartmentAnnals of Emergency Medicine, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Enhancement of Phorbol Ester-Induced Production of Tumor Necrosis Factor α by ThalidomideBiochemical and Biophysical Research Communications, 1994
- Does Proof of Causality Ever Exist in Pharmacovigilance?Drug Safety, 1993
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide in Human Immunodeficiency Virus (HIV) PatientsDrug Safety, 1992
- Studies on the anti-inflammatory properties of thalidomide: Effects on polymorphonuclear leukocytes and monocytesJournal of the American Academy of Dermatology, 1984
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971